HMGB1 is a highly chemoattractant molecule, leading Tregs to the tumor site and suppressing their T-cell proliferative activity, thus promoting a tumor-escape environment in HNSCC patients [27], including OSCC patients. This evidence concerns the gene HMGB1 and head and neck squamous cell carcinoma.